Expert buy, hold and sell recommendations from our team of analysts.
Raymond Chan, Private Adviser & Head of Asian Desk at Morgans, explains why Morgans considers REA a BUY.
Following interim reporting, ANZ Bank, National Australia Bank and Westpac feature prominently with three, two and one upgrades, respectively.
On the eve of the Federal Budget, four expert guests joined Paul Rickard to discuss where investors should be positioning across ETFs, individual stocks and fixed income.
Switzer Investing TV aired its 13 April 2026 edition with a panel of expert investors. Here's what they're looking at on the market, and all their latest stock tips.
The prospects of peace have been a positive fillip for stocks this week with oil prices down from recent highs, though our market did get the nervous 'yips' that golfers suffer when they lose confidence in themselves.
Here are four ETF ideas for conservative yield-focused investors as the cash rate rises.
How should I play the takeover offer for Atlas Arteria? What do the major brokers think of Woodside? Can I sell my entitlements in the BWP capital raising? How do I participate in the NAB Dividend Re-investment Plan, which is issuing shares at a discount?
Michael Gable, Managing Director of Fairmont Equities, shares his view with you on Macquarie Group (MQG).
In this week’s Boom Doom Zoom, we get a question on how to get in on the SpaceX IPO, and cover everything from Tabcorp to Telstra.
Is it time to relook at the healthcare sector? Here are 5 healthcare stocks that could be on the way up. But if you don't want to 'bet' on one company, possibly an ETF like the well-named DRUG, could be an option.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.